Publication | Closed Access

Mesenchymal stem cell treatment is associated with decreased perfusate concentration of interleukin-8 during ex vivo perfusion of donor lungs after 18-hour preservation

Regenerative MedicineCell TherapyTransplantationMedicineStem Cell TransplantationImmunologyAdult Stem CellDonor LungsStem Cell ResearchDecreased Perfusate ConcentrationStem-cell TherapyBiomedical EngineeringMesenchymal Stem CellStem CellsCell TransplantationEx Vivo Perfusion